EXAGEN INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.06 USD | -4.61% |
|
+10.77% | +3.54% |
| 14/05 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
| 13/05 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EXAGEN INC. | Other Healthcare Facilities & Services | -4.61% | +10.77% | +3.54% | -23.97% | - | 37.53M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- XGN Stock
- Charts Exagen Inc.
- Comparison Chart
